Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis

This study has been completed.
Sponsor:
Information provided by:
Deltanoid Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00625326
First received: February 20, 2008
Last updated: April 19, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: December 1, 2010